DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 81 filers reported holding DESIGN THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,540,000 | +12.4% | 1,500,000 | +200.0% | 0.02% | +11.1% |
| Q2 2023 | $3,150,000 | -12.9% | 500,000 | -20.2% | 0.02% | -10.0% |
| Q1 2023 | $3,617,121 | -49.1% | 626,884 | -9.4% | 0.02% | -53.5% |
| Q4 2022 | $7,101,264 | -70.4% | 692,131 | -51.8% | 0.04% | -72.6% |
| Q3 2022 | $24,021,000 | +19.4% | 1,436,636 | 0.0% | 0.16% | +37.7% |
| Q2 2022 | $20,113,000 | -13.3% | 1,436,636 | 0.0% | 0.11% | -14.3% |
| Q1 2022 | $23,202,000 | -24.6% | 1,436,636 | 0.0% | 0.13% | -11.3% |
| Q4 2021 | $30,758,000 | +45.7% | 1,436,636 | 0.0% | 0.15% | +61.3% |
| Q3 2021 | $21,104,000 | -26.1% | 1,436,636 | 0.0% | 0.09% | -25.6% |
| Q2 2021 | $28,575,000 | -33.5% | 1,436,636 | 0.0% | 0.12% | -32.8% |
| Q1 2021 | $42,955,000 | – | 1,436,636 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 2,732,501 | $81,702,000 | 7.97% |
| Cormorant Asset Management, LP | 5,114,850 | $146,409,000 | 3.26% |
| Octagon Capital Advisors LP | 250,000 | $7,475,000 | 2.82% |
| EcoR1 Capital, LLC | 1,137,940 | $34,024,000 | 1.51% |
| RA Capital Management | 2,186,636 | $65,380,000 | 0.99% |
| Avoro Capital Advisors LLC | 1,468,318 | $39,702,000 | 0.69% |
| Vivo Capital, LLC | 530,991 | $15,877,000 | 0.56% |
| Rock Springs Capital Management LP | 327,250 | $9,785,000 | 0.21% |
| Artal Group S.A. | 400,000 | $11,960,000 | 0.21% |
| Baker Brothers Advisors | 1,436,636 | $42,955,000 | 0.19% |